129 related articles for article (PubMed ID: 30425991)
21. Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36.
Kapinsky M; Torzewski M; Büchler C; Duong CQ; Rothe G; Schmitz G
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1004-10. PubMed ID: 11397711
[TBL] [Abstract][Full Text] [Related]
22. Anti-OxLDL IgG blocks OxLDL interaction with CD36, but promotes FcgammaR, CD32A-dependent inflammatory cell adhesion.
Nagarajan S
Immunol Lett; 2007 Jan; 108(1):52-61. PubMed ID: 17081622
[TBL] [Abstract][Full Text] [Related]
23. Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL.
Yassin LM; Londoño J; Montoya G; De Sanctis JB; Rojas M; Ramírez LA; García LF; Vásquez G
Autoimmunity; 2011 May; 44(3):201-10. PubMed ID: 21231894
[TBL] [Abstract][Full Text] [Related]
24. The expression of microvesicles in the blood of patients with Graves' disease and its relationship to treatment.
Mobarrez F; Abraham-Nordling M; Aguilera-Gatica K; Friberg I; Antovic A; Pisetsky DS; Jörneskog G; Wallen H
Clin Endocrinol (Oxf); 2016 May; 84(5):729-35. PubMed ID: 26252432
[TBL] [Abstract][Full Text] [Related]
25. Infrared spectroscopic characterization of monocytic microvesicles (microparticles) released upon lipopolysaccharide stimulation.
Lee J; Wen B; Carter EA; Combes V; Grau GER; Lay PA
FASEB J; 2017 Jul; 31(7):2817-2827. PubMed ID: 28314769
[TBL] [Abstract][Full Text] [Related]
26. Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency.
Hamali HA; Saboor M; Dobie G; Madkhali AM; Akhter MS; Hakamy A; Al-Mekhlafi HM; Jackson DE; Matari YH; Mobarki AA
Infect Drug Resist; 2022; 15():2359-2368. PubMed ID: 35517897
[TBL] [Abstract][Full Text] [Related]
27. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles.
Liu ML; Reilly MP; Casasanto P; McKenzie SE; Williams KJ
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):430-5. PubMed ID: 17158353
[TBL] [Abstract][Full Text] [Related]
28. Consumption of a high-fat meal was associated with an increase in monocyte adhesion molecules, scavenger receptors, and Propensity to Form Foam Cells.
Henning AL; Venable AS; Vingren JL; Hill DW; McFarlin BK
Cytometry B Clin Cytom; 2018 Jul; 94(4):606-612. PubMed ID: 27569052
[TBL] [Abstract][Full Text] [Related]
29. CD36-triggered cell invasion and persistent tissue colonization by tumor microvesicles during metastasis.
Pfeiler S; Thakur M; Grünauer P; Megens RTA; Joshi U; Coletti R; Samara V; Müller-Stoy G; Ishikawa-Ankerhold H; Stark K; Klingl A; Fröhlich T; Arnold GJ; Wörmann S; Bruns CJ; Algül H; Weber C; Massberg S; Engelmann B
FASEB J; 2019 Feb; 33(2):1860-1872. PubMed ID: 30207797
[TBL] [Abstract][Full Text] [Related]
30. Monocyte-Derived Procoagulant Microvesicles Induced by High Glucose Can Be Attenuated by the Antioxidant N-Acetyl-L-Cysteine, Partly Through the P38/MAPK Pathway.
Li M; Zhang X; Yu J; Wu X; Sun L
Metab Syndr Relat Disord; 2017 Dec; 15(10):521-526. PubMed ID: 29125808
[TBL] [Abstract][Full Text] [Related]
31. 4-Hydroxynonenal enhances CD36 expression on murine macrophages via p38 MAPK-mediated activation of 5-lipoxygenase.
Yun MR; Im DS; Lee SJ; Park HM; Bae SS; Lee WS; Kim CD
Free Radic Biol Med; 2009 Mar; 46(5):692-8. PubMed ID: 19135147
[TBL] [Abstract][Full Text] [Related]
32. CML/CD36 accelerates atherosclerotic progression via inhibiting foam cell migration.
Xu S; Li L; Yan J; Ye F; Shao C; Sun Z; Bao Z; Dai Z; Zhu J; Jing L; Wang Z
Biomed Pharmacother; 2018 Jan; 97():1020-1031. PubMed ID: 29136780
[TBL] [Abstract][Full Text] [Related]
33. Elevated Levels of Procoagulant Microvesicles and Tissue-Factor Bearing Microvesicles in Malaria Patients.
Madkhali AM; Mobarki AA; Ghzwani AH; Al-Mekhlafi HM; Zhranei A; Osais A; Sohel A; Othman B; Dobie G; Hamali HA
Int J Gen Med; 2023; 16():1205-1215. PubMed ID: 37041799
[TBL] [Abstract][Full Text] [Related]
34. Microvesicles Correlated with Components of Metabolic Syndrome in Men with Type 2 Diabetes Mellitus and Lowered Testosterone Levels But Were Unaltered by Testosterone Therapy.
Botha J; Velling Magnussen L; Nielsen MH; Nielsen TB; Højlund K; Andersen MS; Handberg A
J Diabetes Res; 2017; 2017():4257875. PubMed ID: 28168203
[No Abstract] [Full Text] [Related]
35. CD36 mRNA expression is increased in CD14+ monocytes of patients with coronary heart disease.
Teupser D; Mueller MA; Koglin J; Wilfert W; Ernst J; von Scheidt W; Steinbeck G; Seidel D; Thiery J
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):552-6. PubMed ID: 18067591
[TBL] [Abstract][Full Text] [Related]
36. Protective effects of circulating microvesicles derived from ischemic preconditioning on myocardial ischemia/reperfusion injury in rats by inhibiting endoplasmic reticulum stress.
Liu M; Wang Y; Zhu Q; Zhao J; Wang Y; Shang M; Liu M; Wu Y; Song J; Liu Y
Apoptosis; 2018 Aug; 23(7-8):436-448. PubMed ID: 29980896
[TBL] [Abstract][Full Text] [Related]
37. Pivotal role for platelet-activating factor receptor in CD36 expression and oxLDL uptake by human monocytes/macrophages.
Rios FJ; Gidlund M; Jancar S
Cell Physiol Biochem; 2011; 27(3-4):363-72. PubMed ID: 21471725
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3.
Wintergerst ES; Jelk J; Rahner C; Asmis R
Eur J Biochem; 2000 Oct; 267(19):6050-9. PubMed ID: 10998066
[TBL] [Abstract][Full Text] [Related]
39. Using image-based flow cytometry to measure monocyte oxidized LDL phagocytosis: A potential risk factor for CVD?
Henning AL; Venable AS; Prado EA; Best Sampson JN; McFarlin BK
J Immunol Methods; 2015 Aug; 423():78-84. PubMed ID: 25858228
[TBL] [Abstract][Full Text] [Related]
40. The role of TLR2, TLR4 and CD36 in macrophage activation and foam cell formation in response to oxLDL in humans.
Chávez-Sánchez L; Garza-Reyes MG; Espinosa-Luna JE; Chávez-Rueda K; Legorreta-Haquet MV; Blanco-Favela F
Hum Immunol; 2014 Apr; 75(4):322-9. PubMed ID: 24486576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
